B-M EXEC VPs BRUCE GELB AND WILLIAM MILLER GET "EXPANDED" ROLES

Executive Summary

B-M EXEC VPs BRUCE GELB AND WILLIAM MILLER GET "EXPANDED" ROLES under an organizational shift in top management announced by the company May 15. The realignment, effective Sept. 1, will coincide with the departure of Health Care Group President James Tuholski, PhD, who is taking early retirement. Since late 1981, the three, with the title of group president, have headed the company's main business groups. Gelb picks up responsibility for the company's health care group in addition to his current overall responsibility for Bristol-Myer's consumer products group, the release explained. Promoted under the reorganization and reporting to Gelb will be former Drackett Div. President Nicholas Evans, who takes over as consumer product group president, and former Senior VP Planning and Development Charles Heimbold Jr., who will head the health care group. Miller retains responsibility for the firm's worldwide pharmaceutical and nutritional businesses. However, under the reorganization, the three divisions headed by Miller have been elevated to group status, with the head of each division assuming the title of group president and reporting to Miller. Wayne Davidson will serve as president of the U.S. pharmaceutical and nutritional group; Joseph Maroun will assume the title of president of Bristol-Myers internatl. group, and Abramo Virgilio, PhD, will be president of the firm's science and technology group.